Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens

被引：0
|
作者：
Susan Swindells
Calvin J Cohen
Daniel S Berger
Karen T Tashima
Qiming Liao
Bonnie F Pobiner
Jerry W Snidow
Gary E Pakes
Jaime E Hernandez
机构：
[1] University of Nebraska Medical Center,HIV Clinic
[2] Community Research Initiative of New England,Infectious Diseases
[3] North Star Medical Center,undefined
[4] Miriam Hospital,undefined
[5] GlaxoSmithKline,undefined
来源：
BMC Infectious Diseases | / 5卷
关键词：
Abacavir; Virologic Failure; Virologic Suppression; Nelfinavir Mesylate; High Hematologic Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
    Swindells, S
    Cohen, CJ
    Berger, DS
    Tashima, KT
    Liao, QM
    Pobiner, BF
    Snidow, JW
    Pakes, GE
    Hernandez, JE
    [J]. BMC INFECTIOUS DISEASES, 2005, 5 (1)
  • [2] Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes
    Chiesa, E
    Bini, T
    Adorni, F
    Capetti, A
    Rizzardini, G
    Faggion, I
    Mussini, C
    Sollima, S
    Melzi, S
    Bongiovanni, M
    Tordato, F
    Cicconi, P
    Castelnuovo, B
    Rusconi, S
    Monforte, AD
    [J]. ANTIVIRAL THERAPY, 2003, 8 (01) : 27 - 35
  • [3] Persistent dyslipidemia in HIV-infected individuals switched from a protease inhibitor-containing to an efavirenz-containing regimen
    Doser, N
    Sudre, P
    Telenti, A
    Wietlisbach, V
    Nicod, P
    Darioli, R
    Mooser, V
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (04) : 389 - 390
  • [4] Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens
    Bonnet, F
    Savès, M
    Droz, C
    Peuchant, E
    Chêne, G
    Beylot, J
    Morlat, P
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (02) : 199 - 200
  • [5] A prospective cohort study on the risk for lipodystrophy in HIV-infected patients treated with protease inhibitor-containing regimens.
    Martínez, E
    Mocroft, A
    García-Viejo, MA
    Pérez-Cuevas, JB
    Bianco, JL
    Mallolas, J
    Bianchi, L
    Conget, I
    Gatell, JM
    [J]. AIDS, 2000, 14 : S55 - S55
  • [6] Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy -: Standardization to the general population
    Lewden, C
    Raffi, F
    Chêne, G
    Sobel, A
    Leport, C
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (05) : 480 - 482
  • [7] Activity of combination abacavir/amprenavir/efavirenz therapy in HIV-1 infected subjects failing their current protease inhibitor containing regimen
    Eron, J
    Falloon, J
    Masur, H
    Ait-Khaled, M
    Thomas, D
    Manion, D
    Rogers, M
    [J]. AIDS, 1998, 12 : S13 - S13
  • [8] Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens
    Fumaz, CR
    Tuldrà, A
    Ferrer, J
    Paredes, R
    Bonjoch, A
    Jou, T
    Negredo, E
    Romeu, J
    Sirera, G
    Tural, C
    Clotet, B
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (03) : 244 - 253
  • [9] Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy
    Tenorio, AR
    Irlanda, IE
    Narkiewicz, E
    Smith, KY
    Kessler, HA
    Sha, BE
    [J]. AIDS, 2000, 14 (10) : 1470 - 1471
  • [10] Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir
    Abgrall, Sophie
    Yeni, Patrick G.
    Bouchaud, Olivier
    Costagliola, Dominique
    [J]. AIDS, 2006, 20 (16) : 2099 - 2106
12345